
3 Key Copyright Assignment Points From Lawyer NY Attorney: Written agreement required, ownership transfer must be explicit, registration protects enforceability. Copyright assignment is one of the most mishandled transactions in intellectual property practice. Many creators and businesses enter into agreements believing they have transferred or retained rights, only to discover later that the language was ambiguous, the transfer was incomplete, or the assignment failed to account for derivative works or future modifications. A copyright attorney in NY can help you navigate these pitfalls and ensure that your assignment agreement reflects your actual business intent and protects your interests.
阅读更多

New York car accident settlement form requirements for Bronx claims may involve settlement formalities, filing deadlines, payment rules, and court approval. Bronx claims follow New York State law rather than a separate Bronx settlement statute. The applicable requirements depend in part on whether the matter remains an insurance claim or is already in litigation. Release language also determines which claims and parties are covered by the agreement.
阅读更多

Learn how a postnuptial agreement attorney helps business owners protect business interests, separate property, and marital assets through legally enforceable agreements. A postnuptial agreement attorney helps married couples, especially business owners, create legally enforceable agreements that protect business interests, separate property, and financial stability. A well-drafted postnuptial agreement attorney strategy can reduce uncertainty if future disputes arise while ensuring the agreement satisfies New York legal standards. From my experience, carefully defining ownership and financial expectations today often prevents far more difficult conflicts later. Working with a postnuptial agreement attorney early also makes future negotiations more predictable.
阅读更多

A brand well known abroad has no U.S. .ights until it registers or uses the mark here. That is the first obstacle for foreign companies. U.S. .rademark rights arise from use in commerce or registration, not from reputation elsewhere. Filing based on a home country registration is available, and so is designating the United States through the Madrid Protocol — but a registration obtained that way is vulnerable to cancellation if the mark is never actually used here. Parallel imports are usually lawful. Genuine goods sold through channels the brand did not authorize are generally permitted. The exception is material difference — where the imported product differs from the authorized U.S. .ersion in composition, packaging, labeling, or warranty coverage. Establishing that difference is what turns a gray market problem into an infringement claim. Customs recordation does more than litigation for most brands. A mark recorded with CBP can be enforced at the border, where infringing goods are seized before they reach a distributor. It costs a fraction of a lawsuit. For imported goods, an ITC proceeding is faster than district court, and the remedy is exclusion from the U.S. .arket rather than damages. And a judgment against an overseas seller is often unenforceable. Which is why platform takedowns, payment processor action, and border seizure carry more practical weight than a favorable decision nobody can collect on.
阅读更多

Global foreign direct investment refers to the cross-border transfer of capital, assets, and management control by an investor from one country into a business enterprise in another country, subject to a complex web of bilateral treaties, multilateral agreements, and domestic regulatory regimes. Most foreign direct investment transactions require compliance with host-country screening mechanisms, capital controls, and sectoral restrictions that vary significantly by jurisdiction and industry. Violations of these frameworks can result in deal termination, asset seizure, sanctions exposure, or denial of treaty protections. This article examines the statutory and treaty-based requirements that shape FDI posture, the procedural safeguards available to investors, and the strategic considerations that influence investment structure and timing.
阅读更多

The FDA drug approval process is the federal regulatory pathway by which new pharmaceutical products are evaluated for safety and efficacy before they may be marketed in the United States. The process requires sponsors to submit comprehensive clinical and manufacturing data through a structured application framework, with specific timelines and decision points at each stage. Failure to meet procedural requirements, data standards, or submission deadlines can result in a Refuse to File (RTF) action, which delays market entry and may require substantial resubmission work. This article covers the key phases of drug development and approval, the roles of healthcare professionals in clinical trials, post-approval compliance obligations, and the appeals pathways available when regulatory decisions are challenged.
阅读更多
